AboutBlogOver 40,000+ FDA inspection documents: 483s, EIRs, 483Rs

483 Stelis Biopharma, Jul 2022

$119 - Available for instant download

FDA investigators audited the Stelis Biopharma - Bengaluru, India facility and issued inspectional observations (via FDA 483) on 19 Jul 2022.

Product Details

  • Category: Human Drugs
  • Inspection end: 19 Jul 2022
  • Location: Bengaluru, India
  • FEI: 3017501030
Stelis Biopharma FDA inspection 483 Jul 2022